These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2341244)

  • 1. The combined use of busulfan and hydroxyurea in the treatment of chronic myeloid leukemia.
    Jim RT
    Hawaii Med J; 1990 Apr; 49(4):133-4. PubMed ID: 2341244
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
    J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 4. [A modern therapeutic strategy in Ph-positive chronic myeloleukemia].
    Khoroshko ND; Turkina AG; Zhuravlev VS; Sokolova MA; Mikhaĭlova IN; Zakharova AV; Domracheva EV; Semenova EA
    Ter Arkh; 1996; 68(7):22-7. PubMed ID: 8928067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myeloid crisis of chronic myelogenous leukemia showing dramatic response to mithramycin and hydroxyurea combination].
    Ueki K; Tsuchida A; Murakami H; Karasawa M; Kobayashi N; Omine M; Naruse T
    Rinsho Ketsueki; 1989 Oct; 30(10):1840-2. PubMed ID: 2531808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
    Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
    Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy of chronic myeloid leukemia].
    Rák K
    Orv Hetil; 2003 Mar; 144(9):405-12. PubMed ID: 12688234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha-interferons in the treatment of patients with chronic myeloid leukemia].
    Abdulkadyrov KM; Udal'eva VIu; Rukavitsyn OA; Bessmel'tsev SS
    Vopr Onkol; 1999; 45(4):387-92. PubMed ID: 10532097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two siblings with chronic myelogenous leukemia.
    Kapsali E; Tsiara S; Christou L; Panteli A; Bourantas KL
    J Exp Clin Cancer Res; 2000 Dec; 19(4):541-3. PubMed ID: 11277336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulating effect of antileukemia drugs on the cellular susceptibility in chronic myeloid leukemia to cytotoxic lymphocytes].
    Cherepovich VS; Shakhlevich EV; Antonenko EV; Lotkova ES; Grinëv VV
    Vopr Onkol; 2006; 52(4):417-20. PubMed ID: 17024814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First case in Tunisia of PH1 positive chronic myelogenous leukemia in a 3 year old child.
    Toumi NH; Ben Abid H; Meddeb B; Ben Othman T; Trabelsi C; Boukef K; Hafsia A
    Nouv Rev Fr Hematol (1978); 1991; 33(3):275-6. PubMed ID: 1956767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
    Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
    Takami A; Chuhjo T; Nakao S
    Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
    [No Abstract]   [Full Text] [Related]  

  • 15. Autotransplantation for chronic myeloid leukemia: is it useful?
    Olavarria E
    Haematologica; 2002 Jan; 87(1):3-6. PubMed ID: 11801458
    [No Abstract]   [Full Text] [Related]  

  • 16. ICE, mini-ICE or high-dose hydroxyurea to mobilize Philadelphia (Ph1)-negative PBPC in chronic myelogenous leukaemia.
    Carella AM; Frassoni F
    Br J Haematol; 1996 Oct; 95(1):213-5. PubMed ID: 8857964
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bestatin therapy of chronic myelogenous leukemia].
    Uzuka Y; Saito Y
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):207-14. PubMed ID: 8434958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symmetrical foot ulcer in chronic myeloid leukemia treated with hydroxyurea (Litalir)].
    Reichenberger F
    Praxis (Bern 1994); 1998 Oct; 87(41):1370-2. PubMed ID: 9828669
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.
    Avalos BR; Klein JL; Kapoor N; Copelan EA
    Bone Marrow Transplant; 1993 Dec; 12(6):655-8. PubMed ID: 8136749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.